Products

OM1 Patient Finder
OM1
Clinical Decision Support & Reference
OM1 Patient Finder uses AI and extensive real-world clinical data to identify individuals most likely to be affected by a target condition, enhancing research productivity and clinical decision-making.

See all 1 product →

About OM1

OM1 is a healthcare AI company that specializes in leveraging real-world data and artificial intelligence to measure and predict health outcomes, accelerate medical research, and improve clinical decision-making. For physicians, OM1’s platform offers actionable insights by aggregating and analyzing large-scale clinical data, including electronic health records (EHRs) and laboratory results. This allows for a comprehensive view of patient journeys and treatment effectiveness, bridging the gap between traditional clinical evidence and the dynamic needs of healthcare. [3, 11]

Through its proprietary PhenOM™ AI foundation model, trained on billions of patient-years, OM1 can identify patient phenotypes, accelerate diagnoses, and predict future medical events, risks, and responses to treatment. [9] This capability assists providers in patient and population management, helping to identify and triage patients based on unrecognized conditions, health risks, and gaps in care. [14] OM1 also supports quality improvement and research by automating data abstraction for quality registries and offering participation in research networks, potentially providing new revenue streams from studies. [14]

Focus Areas

Real-World Evidence (RWE) Personalized Medicine Outcomes Measurement Predictive Analytics Chronic Disease Management AI in Healthcare Clinical Registries Data Modeling Decision Support

Business Intelligence

Key InvestorsD1 Capital Partners, Kaiser Permanente, Breyer Capital, General Catalyst, Polaris Partners, Scale Venture Partners, 7wire Ventures, Glikvest, A Capital, Arbor Ventures, Benchmark, Bessemer Venture Partners, Cisco Investments, Citi Ventures, Felix Capital, L Catterton, Lightspeed Venture Partners, March Capital, NewView Capital, Next47, PS Investments, Sequoia Capital Israel, Summit Partners, SV Angel
TechnologyOM1 Real-World Data Cloud, PhenOM® Foundation Model (AI-powered, trained on billions of patient-years, utilizes digital phenotyping, natural language processing, EMR integration, predictive modeling), OM1 Aspen platform, cloud-native

What Physicians Need to Know

Real-World Evidence (RWE)
OM1 is a leader in generating regulatory-grade real-world evidence by leveraging extensive clinical networks and AI platforms. They use real-world data (RWD) from over 350 million patients, including electronic health records (EHR), claims, and specialty networks, to provide insights for drug development, market access, and regulatory decision-making. Their platform has supported large-scale RWE studies, including one for an FDA approval involving over 650,000 patients.
Personalized Medicine
OM1 specializes in personalized medicine through its AI-powered digital phenotyping platform, PhenOMu2122. This platform, trained on over 1 billion patient-years of data, identifies patient phenotypes, accelerates diagnoses, uncovers subtypes, estimates treatment effects, and predicts future medical events, risks, and responses to treatment. They offer products like OM1 Lyra, designed to provide personalized insights for clinicians and patients to guide treatment decisions.
Outcomes Measurement
OM1 focuses on the measurement, comparison, and prediction of real-world treatment outcomes. They enrich data by using AI and other technologies to understand health outcomes, which helps in understanding the natural history of a disease and predicting what might happen to a patient over time.
Predictive Analytics
OM1's cutting-edge AI foundation model is trained on billions of patient-years to predict future medical events, risks, and responses to treatment. Their PhenOMu00ae AI model powers digital phenotyping and medical event predictions, accelerating patient finding for undiagnosed conditions and forecasting outcomes for individuals and populations.
Chronic Disease Management
OM1 specializes in chronic conditions, developing large electronically connected networks of clinicians and health data across various specialty areas like rheumatology, dermatology, gastroenterology, cardiometabolic, respiratory, mental health, and central nervous system. They aim to improve the management of chronic conditions by analyzing health outcomes data.
AI in Healthcare
OM1 is a pioneer in leveraging AI in real-world data, with their PhenOMu00ae AI foundation model being a core technology. This AI is used for digital phenotyping, accelerating diagnoses, identifying condition subtypes, and predicting medical events and disease outcomes. They also use AI for extracting key variables from unstructured clinical notes, images, and reports, converting them into structured data.
Clinical Registries
OM1 offers unmatched experience and automation in clinical registries and observational studies, reducing burden for sites and patients while generating regulatory-ready evidence. They have experience with over 300 registries and observational studies and have launched specific registries for conditions like Multiple Sclerosis. Their Registries Center of Excellence provides expertise and consultation for the entire project lifecycle.
Data Modeling
OM1 provides research analytics, data modeling, and custom analytics services. They aggregate and enrich patient outcomes data from large electronically connected networks of clinicians and health data across numerous chronic conditions, processing vast amounts of structured and unstructured information through their intelligent data cloud.
Decision Support
OM1 offers AI-driven decision support tools that provide personalized predictions to improve treatment decision quality and patient outcomes. An example is their Joint Insights tool, which leverages predictive models to generate personalized predictions of benefit and risk for knee osteoarthritis patients considering total knee replacement.
Physician Tip

For physicians, OM1's solutions offer several key advantages. Their AI-powered platforms, particularly PhenOMu2122, can accelerate diagnoses and identify specific patient subtypes, leading to more precise and personalized treatment strategies. The predictive analytics can forecast future medical events and treatment responses, enabling proactive care and improved patient outcomes. OM1's decision support tools, like Joint Insights, provide individualized predictions of treatment benefit and risk, facilitating shared decision-making with patients. Furthermore, their automated clinical registries reduce the administrative burden on sites and patients, allowing physicians to focus more on patient care while still contributing to valuable research.

OM1's platform is designed to integrate with major Electronic Medical Records (EMRs) and can work standalone or fully integrated. They leverage an 'Agentic Health Data Framework' for automating data capture, processing, and enrichment, ensuring faster and more reliable insights. Their data automation capabilities streamline data acquisition and enrichment across diverse data sources. They also utilize platforms like Snowflake for managing and analyzing their extensive datasets.

Products by OM1

1 product in the directory

OM1 Patient Finder
OM1
Clinical Decision Support & Reference
OM1 Patient Finder uses AI and extensive real-world clinical data to identify individuals most likely to be affected by a target condition, enhancing research productivity and clinical decision-making.

What the Web Says

Due to the prevalence of reviews for the 'OM SYSTEM OM-1' camera, comprehensive product and employer reviews for the healthcare technology company 'OM1' (om1.com) from the requested sources (G2, Glassdoor, Capterra, healthcare IT reviewers, Reddit) could not be found. Some limited employer reviews for similarly named companies 'Om1, Inc.' and 'OM Healthcare' were found on Indeed.com, but these do not appear to be for the target company.

Overall: Neutral

Limitations

No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.

Last updated: 2026-07-04

Videos

News, demos, and interviews about OM1.

Loading videos...

Videos load interactively. If none appear, search YouTube for OM1 →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

OM1 offers several AI-powered platforms and products, including PhenOMu2122, their foundational AI model for digital phenotyping and medical event prediction. This powers solutions like OM1 Orion for comprehensive patient journey views, OM1 Lyra for personalized treatment insights at the point of care, and OM1 Polaris for optimizing clinical trial recruitment. They also provide the OM1 Aspen platform for automated data collection and analysis for studies and registries.
OM1 specializes in aggregating and enriching patient outcomes data from large electronically connected networks, including EMR, claims, and specialty networks. They emphasize generating high-quality, traceable, and auditable data using systems and procedures that have met regulatory expectations, supporting regulatory submissions with robust real-world evidence.
OM1's PhenOM platform is designed to provide customized healthcare inputs across the entire healthcare ecosystem, including point-of-care clinical decision-making. For example, their Joint Insights tool, powered by PhenOM, is integrated into Dell Medical School's EHR system to provide individualized predictions for knee osteoarthritis patients.
OM1 offers scientific and consulting services with experts in data science, epidemiology, AI, and regulatory strategy. They assist in designing and executing fit-for-purpose programs, aligning evidence with requirements, and maximizing the value of AI and real-world data. They also recently launched a Registries Center of Excellence to provide unparalleled subject matter expertise and consultation for patient registries.
Founded in 2015, OM1 is a privately held company that has raised a total of $171 million in funding over four rounds. They have expanded into Europe to meet the growing demand for AI-powered RWE solutions and have been recognized with awards for their innovation in the real-world evidence analytics industry.
OM1 focuses on chronic conditions and leverages AI and machine learning to aggregate and enrich patient outcomes data from extensive clinical networks. This allows them to better understand disease progression, compare treatment outcomes, and predict future events, offering a more precise and data-driven approach than traditional methods.
OM1 partners with life sciences innovators, providers (health systems, specialty networks, medical associations), and payers. Their collaborations aim to transform real-world data into evidence that improves patient outcomes, accelerates research, and enhances care and value across the healthcare ecosystem.

Investors

Who's funded OM1.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.